Jul 3, 2024
SPARK Finland, summer break
Once again, a great spring season at SPARK Finland has come to an end, and it is time to enjoy the summer break. Our management team will also enjoy a…
May 17, 2024
SPARK Finland, SPARK at Stanford, Stanford University, SPARK Norway, Nordic SPARK programs, UCSF, Berkeley, SDDS 2024
Nordic SPARK programs have had years of successful collaboration in boosting the emergence of new value-creating solutions in the health tech and life science fields. Once again, we were on…
Mar 22, 2024
SPARK Finland, SPARK Norway, Nordic SPARK programs, UCSF, Silicon Valley Tour, Stanford Drug Discovery Symposium 2024, SDDS, Stanford, Berkeley
Nordic SPARK programs have had years of successful collaboration in boosting the emergence of new value-creating solutions in the health tech and life science fields. It has resulted in multiple…
Feb 12, 2024
In December 2023, the SPARK Finland consortium signed a four-year program agreement for years 2024-2027. This is a continuation of the journey that started officially in spring 2017. SPARK Finland has…
May 30, 2023
SPARK Finland, SPARK Norway, SPARK Denmark, European SPARK network, Nordic SPARK programs
Nordic SPARK programs are deepening collaboration in developing program offering. Last week, program directors of SPARK Finland, SPARK Norway and SPARK Denmark were designing next steps for their collaborative activities.…
Apr 19, 2023
SPARK Finland, Stanford University, SPARK Norway, SPARK Denmark, Nordic SPARK programs, Silicon Valley, Stanford Drug Discovery Symposium 2023, UCSF
Nordic SPARK programs have had years of successful collaboration in boosting emergence of new cool solutions in health tech and life science field. Collaboration in mentoring of the projects started…
Mar 31, 2023
SPARKee, SPARK Finland, Sartar Therapeutics, DecoDerma, Orphan drug designation, FDA, EMA, alumni
Finnish SPARKee Decoderma and alumni Sartar Therapeutics have announced recently fantastic news regarding their progress in drug development process. Orphan drug status is assigned to a medicine intended for use…
Nov 18, 2022
SPARK Finland, Amanda Paananen, Management Team, Anu Meerwaldt
We are truly thrilled to announce that Anu Meerwaldt has joined SPARK Finland management team. Amanda Paananen, Development Manager of Helsinki capital region, is now on her leave and will…
Nov 3, 2022
SPARK Finland, Koite Health, Lumoral, Open call, Tommi Pätilä, co-founder, SpectroCor
Call for SPARK Finland program is once again open. Twice a year – in May/June and Nov/Dec – an expert panel of faculty and industry advisors reviews proposals submitted from…
Oct 19, 2022
DecoDerma, Tero Järvinen, Albert Lasker Medical Research Award, Orphan drug designation, Erkki Ruoslahti
Dr. Erkki Ruoslahti (MD, PhD), the chairman of the advisory board for the Finnish SPARK project DecoDerma, is one of three winners of the Albert Lasker Medical Research Award in…